Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2016, Article ID 4156293, 16 pages
http://dx.doi.org/10.1155/2016/4156293
Review Article

Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology

1CICS-UBI, Health Sciences Research Centre, Universidade da Beira Interior, Covilhã, Portugal
2Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, Covilhã, Portugal
3Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal

Received 8 September 2016; Revised 8 November 2016; Accepted 17 November 2016

Academic Editor: Angela Chambery

Copyright © 2016 Mafalda Jesus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Jiang, J. Fan, Q. Wang et al., “Diosgenin induces ROS-dependent autophagy and cytotoxicity via mTOR signaling pathway in chronic myeloid leukemia cells,” Phytomedicine, vol. 23, no. 3, pp. 243–252, 2016. View at Publisher · View at Google Scholar
  2. J. A. R. Salvador, J. F. S. Carvalho, M. A. C. Neves et al., “Anticancer steroids: linking natural and semi-synthetic compounds,” Natural Product Reports, vol. 30, no. 2, pp. 324–374, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Q.-Y. Tong, Y. He, Q.-B. Zhao, Y. Qing, W. Huang, and X.-H. Wu, “Cytotoxicity and apoptosis-inducing effect of steroidal saponins from Dioscorea zingiberensis Wright against cancer cells,” Steroids, vol. 77, no. 12, pp. 1219–1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Podolak, A. Galanty, and D. Sobolewska, “Saponins as cytotoxic agents: a review,” Phytochemistry Reviews, vol. 9, no. 3, pp. 425–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Chen, Y.-M. Tang, S.-L. Yu et al., “Advances in the pharmacological activities and mechanisms of diosgenin,” Chinese Journal of Natural Medicines, vol. 13, no. 8, pp. 578–587, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Selim and S. Al Jaouni, “Anticancer and apoptotic effects on cell proliferation of diosgenin isolated from Costus speciosus (Koen.) Sm,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article no. 301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Raju and R. Mehta, “Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin,” Nutrition and Cancer, vol. 61, no. 1, pp. 27–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Shao, H. Guo, Y. Cui, M. Ye, J. Han, and D. Guo, “Steroidal saponins from Smilax china and their anti-inflammatory activities,” Phytochemistry, vol. 68, no. 5, pp. 623–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Dong, C. Lei, D. Lu, and Y. Wang, “Direct biotransformation of dioscin into diosgenin in rhizome of Dioscorea zingiberensis by Penicillium dioscin,” Indian Journal of Microbiology, vol. 55, no. 2, pp. 200–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Al Jasem, M. Khan, A. Taha, and T. Thiemann, “Preparation of steroidal hormones with an emphasis on transformations of phytosterols and cholesterol—a review,” Mediterranean Journal of Chemistry, vol. 3, no. 2, pp. 796–830, 2014. View at Publisher · View at Google Scholar
  11. B. Huang, D. Du, R. Zhang et al., “Synthesis, characterization and biological studies of diosgenyl analogues,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 24, pp. 7330–7334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Raju and C. V. Rao, “Diosgenin, a steroid saponin constituent of yams and fenugreek: emerging evidence for applications in medicine,” in Bioactive Compounds in Phytomedicine, pp. 125–142, InTech, 2012. View at Google Scholar
  13. H. Yang, H. Yin, Y. Shen et al., “A more ecological and efficient approach for producing diosgenin from Dioscorea zingiberensis tubers via pressurized biphase acid hydrolysis,” Journal of Cleaner Production, vol. 131, pp. 10–19, 2016. View at Publisher · View at Google Scholar
  14. V. K. Manda, B. Avula, Z. Ali et al., “Characterization of in vitro ADME properties of diosgenin and dioscin from dioscorea villosa,” Planta Medica, vol. 79, no. 15, pp. 1421–1428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Manivannan, P. Arunagiri, J. Sivasubramanian, and E. Balamurugan, “Diosgenin prevents hepatic oxidative stress, lipid peroxidation and molecular alterations in chronic renal failure rats,” International Journal of Nutrition, Pharmacology, Neurological Diseases, vol. 3, no. 3, pp. 289–294, 2013. View at Publisher · View at Google Scholar
  16. F. Roghani-Dehkordi, M. Roghani, and T. Baluchnejadmojarad, “Diosgenin mitigates streptozotocin diabetes-induced vascular dysfunction of the rat aorta: the involved mechanisms,” Journal of Cardiovascular Pharmacology, vol. 66, no. 6, pp. 584–592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K.-W. Choi, H.-J. Park, D.-H. Jung et al., “Inhibition of TNF-α-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via downregulation of the MAPK, Akt and NF-κB signaling pathways,” Vascular Pharmacology, vol. 53, no. 5-6, pp. 273–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Esfandiarei, J. T. N. Lam, S. A. Yazdi et al., “Diosgenin modulates vascular smooth muscle cell function by regulating cell viability, migration, and calcium homeostasis,” Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 3, pp. 925–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Liu, W. Zhao, X. Gao, F. Huang, J. Kou, and B. Liu, “Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways,” Atherosclerosis, vol. 223, no. 2, pp. 350–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-P. Yang, L. Yue, W.-W. Jiang, Q. Liu, J.-P. Kou, and B.-Y. Yu, “Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-κB, Akt, and MAPK signaling pathways,” Chinese Journal of Natural Medicines, vol. 11, no. 6, pp. 608–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Kalailingam, B. Kannaian, E. Tamilmani, and R. Kaliaperumal, “Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats,” Phytomedicine, vol. 21, no. 10, pp. 1154–1161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Gong, Y. Qin, and W. Huang, “Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright in vitro and in vivo,” Phytomedicine, vol. 18, no. 6, pp. 458–463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P.-S. Chen, Y.-W. Shih, H.-C. Huang, and H.-W. Cheng, “Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer pc-3 cells by reducing matrix metalloproteinases expression,” PLoS ONE, vol. 6, no. 5, Article ID e20164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lepage, D. Y. Léger, J. Bertrand, F. Martin, J. L. Beneytout, and B. Liagre, “Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells,” Cancer Letters, vol. 301, no. 2, pp. 193–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. S. Kim, B. K. Jeon, Y. E. Lee, W. H. Woo, and Y. J. Mun, “Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 981675, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. A. Hamid, M. Hasanain, A. Singh et al., “Synthesis of novel anticancer agents through opening of spiroacetal ring of diosgenin,” Steroids, vol. 87, pp. 108–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Y. Léger, B. Liagre, P. Jean et al., “Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring,” Analytical Biochemistry, vol. 335, no. 2, pp. 267–278, 2004. View at Publisher · View at Google Scholar
  28. S. Das, K. K. Dey, G. Dey et al., “Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma,” PLoS ONE, vol. 7, no. 10, Article ID e46641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Li, X. Wang, S. Cheng et al., “Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells,” Oncology Reports, vol. 33, no. 2, pp. 693–698, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. Z.-J. Mao, Q.-J. Tang, C.-A. Zhang et al., “Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1α shRNAS,” International Journal of Molecular Sciences, vol. 13, no. 5, pp. 6521–6533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Y. Mohammad, G. Somayyeh, H. Gholamreza, M. Majid, and R. Yousef, “Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6945–6948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Sung, S. Prasad, V. R. Yadav, and B. B. Aggarwal, “Cancer cell signaling pathways targeted by spice-derived nutraceuticals,” Nutrition and Cancer, vol. 64, no. 2, pp. 173–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Patel, M. Gadewar, and R. Tripathi, “A review on pharmacological and analytical aspects of diosgenin: a concise report,” Natural Products and Bioprospecting, vol. 2, no. 2, pp. 46–52, 2012. View at Publisher · View at Google Scholar
  34. S. Ghosh, P. More, A. Derle et al., “Diosgenin functionalized iron oxide nanoparticles as novel nanomaterial against breast cancer,” Journal of Nanoscience and Nanotechnology, vol. 15, no. 12, pp. 9464–9472, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Corbiere, B. Liagre, A. Bianchi et al., “Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells,” International Journal of Oncology, vol. 22, no. 4, pp. 899–905, 2003. View at Google Scholar · View at Scopus
  36. S. Srinivasan, S. Koduru, R. Kumar, G. Venguswamy, N. Kyprianou, and C. Damodaran, “Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells,” International Journal of Cancer, vol. 125, no. 4, pp. 961–967, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Rahmati-Yamchi, S. Ghareghomi, G. Haddadchi, M. Milani, M. Aghazadeh, and H. Daroushnejad, “Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line,” Molecular Biology Reports, vol. 41, no. 9, pp. 6247–6252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Y. Leger, B. L. I. Liagre, C. Corbière, J. Cook-Moreau, and J.-L. Beneytout, “Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression,” International journal of oncology, vol. 25, no. 3, pp. 555–562, 2004. View at Google Scholar · View at Scopus
  39. B. Liagre, J. Bertrand, D. Y. Leger, and J.-L. Beneytout, “Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding,” International Journal of Molecular Medicine, vol. 16, no. 6, pp. 1095–1101, 2005. View at Google Scholar · View at Scopus
  40. M.-J. Liu, Z. Wang, Y. Ju, R. N.-S. Wong, and Q.-Y. Wu, “Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis,” Cancer Chemotherapy and Pharmacology, vol. 55, no. 1, pp. 79–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Li, P. P. Fernandez, P. Rajendran, K. M. Hui, and G. Sethi, “Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells,” Cancer Letters, vol. 292, no. 2, pp. 197–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. He, H. Chen, G. Li et al., “Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity,” Phytomedicine, vol. 21, no. 6, pp. 871–876, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. B. N. P. Kumar, N. Puvvada, S. Rajput et al., “Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy,” Journal of Materials Chemistry B, vol. 3, no. 1, pp. 90–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Li, L. Dai, K. Liu, L. Deng, T. Pei, and J. Lei, “A self-assembled nanoparticle platform based on poly(ethylene glycol)-diosgenin conjugates for co-delivery of anticancer drugs,” RSC Advances, vol. 5, no. 91, pp. 74828–74834, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. D.-H. Jung, H.-J. Park, H.-E. Byun et al., “Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-κB and AP-1 activation,” International Immunopharmacology, vol. 10, no. 9, pp. 1047–1054, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Lin, R. Jia, Y. Liu et al., “Diosgenin inhibits superoxide generation in FMLP-activated mouse neutrophils via multiple pathways,” Free Radical Research, vol. 48, no. 12, pp. 1485–1493, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Chen, X. Xu, Y. Zhang et al., “Diosgenin regulates adipokine expression in perivascular adipose tissue and ameliorates endothelial dysfunction via regulation of AMPK,” Journal of Steroid Biochemistry and Molecular Biology, vol. 155, pp. 155–165, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-H. Huang, C.-Y. Ku, and T.-R. Jan, “Diosgenin attenuates allergen-induced intestinal inflammation and IgE production in a murine model of food allergy,” Planta Medica, vol. 75, no. 12, pp. 1300–1305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. L. A. Ahmed, A. A. Z. Obaid, H. F. Zaki, and A. M. Agha, “Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats,” European Journal of Pharmacology, vol. 740, pp. 379–387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. J. E. Kim, J. Go, E. K. Koh et al., “Diosgenin effectively suppresses skin inflammation induced by phthalic anhydride in IL-4/Luc/CNS-1 transgenic mice,” Bioscience, Biotechnology, and Biochemistry, vol. 80, no. 5, pp. 891–901, 2016. View at Publisher · View at Google Scholar
  51. L. Wang, T. Ma, Y. Zheng, S. Lv, Y. Li, and S. Liu, “Diosgenin inhibits IL-1β-induced expression of inflammatory mediators in human osteoarthritis chondrocytes,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4830–4836, 2015. View at Google Scholar · View at Scopus
  52. Y. Guo, E. Xing, X. Liang, H. Song, and W. Dong, “Effects of total saponins from Rhizoma Dioscoreae nipponicae on expression of vascular endothelial growth factor and angiopoietin-2 and Tie-2 receptors in the synovium of rats with rheumatoid arthritis,” Journal of the Chinese Medical Association, vol. 79, no. 5, pp. 264–271, 2016. View at Publisher · View at Google Scholar
  53. M. Sautour, T. Miyamoto, and A. Dongmo, “Antifungal steroid saponins from dioscorea cayenensis,” Planta Medica, vol. 70, no. 1, pp. 90–92, 2004. View at Publisher · View at Google Scholar
  54. C.-R. Yang, Y. Zhang, M. R. Jacob, S. I. Khan, Y.-J. Zhang, and X.-C. Li, “Antifungal activity of C-27 steroidal saponins,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 5, pp. 1710–1714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Khan, M. Saeed, A. Rauf, M. A. Khan, and N. Muhammad, “Antimicrobial and inhibition on heat-induced protein denaturation of constituents isolated from Polygonatum verticillatum rhizomes,” Natural Product Research, vol. 29, no. 22, pp. 2160–2163, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Rabablert, S. Tiewcharoen, P. Auewarakul et al., “Anti-amebic activity of diosgenin on Naegleria fowleri trophozoites,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 46, pp. 827–834, 2015. View at Google Scholar
  57. J. Turchan, C. B. Pocernich, C. Gairola et al., “Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants,” Neurology, vol. 60, no. 2, pp. 307–314, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. Y.-J. Wang, K.-L. Pan, T.-C. Hsieh, T.-Y. Chang, W.-H. Lin, and J. T.-A. Hsu, “Diosgenin, a plant-derived sapogenin, exhibits antiviral activity in vitro against hepatitis C virus,” Journal of Natural Products, vol. 74, no. 4, pp. 580–584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. K. Sangeetha, N. Shrishri Mal, K. Atmaja, V. K. Sali, and H. R. Vasanthi, “PPAR's and Diosgenin a chemico biological insight in NIDDM,” Chemico-Biological Interactions, vol. 206, no. 2, pp. 403–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. D. M. Kanchan, G. S. Somani, V. V. Peshattiwar, A. A. Kaikini, and S. Sathaye, “Renoprotective effect of diosgenin in streptozotocin induced diabetic rats,” Pharmacological Reports, vol. 68, no. 2, pp. 370–377, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Fuller and J. M. Stephens, “Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome,” Advances in Nutrition, vol. 6, no. 2, pp. 189–197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. I. S. Son, J. H. Kim, H. Y. Sohn, K. H. Son, J.-S. Kim, and C.-S. Kwon, “Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 12, pp. 3063–3071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. T. E. Harijono, A. D. Ariestiningsih, and N. A. K. Wardani, “The effect of crude diosgenin extract from purple and yellow greater yams (Dioscorea alata) on the lipid profile of dyslipidemia rats,” Emirates Journal of Food and Agriculture, vol. 28, pp. 506–512, 2016. View at Google Scholar
  64. T. Uemura, S. Hirai, N. Mizoguchi et al., “Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues,” Molecular Nutrition and Food Research, vol. 54, no. 11, pp. 1596–1608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Uemura, T. Goto, M.-S. Kang et al., “Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice,” Journal of Nutrition, vol. 141, no. 1, pp. 17–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. Y.-C. Lv, J. Yang, F. Yao et al., “Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1,” Atherosclerosis, vol. 240, no. 1, pp. 80–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Saravanan, P. Ponmurugan, M. A. Deepa, and B. Senthilkumar, “Modulatory effects of diosgenin on attenuating the key enzymes activities of carbohydrate metabolism and glycogen content in streptozotocin-induced diabetic rats,” Canadian Journal of Diabetes, vol. 38, no. 6, pp. 409–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Ghosh, P. More, A. Derle et al., “Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase,” PLoS ONE, vol. 9, no. 9, Article ID e106039, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Mayakrishnan, J. R. Nakkala, S. P. K. Jeepipalli et al., “Fenugreek seed extract and its phytocompounds- trigonelline and diosgenin arbitrate their hepatoprotective effects through attenuation of endoplasmic reticulum stress and oxidative stress in type 2 diabetic rats,” European Food Research and Technology, vol. 240, no. 1, pp. 223–232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. W.-C. Wang, S.-F. Liu, W.-T. Chang et al., “The effects of diosgenin in the regulation of renal proximal tubular fibrosis,” Experimental Cell Research, vol. 323, no. 2, pp. 255–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Zhang, B. Huang, D. Du et al., “Anti-thrombosis effect of diosgenyl saponins in vitro and in vivo,” Steroids, vol. 78, no. 11, pp. 1064–1070, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Zheng, Z. Wei, G. Xin et al., “Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo,” Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 14, pp. 3364–3369, 2016. View at Publisher · View at Google Scholar
  73. W. Li, H. Wang, Z. Wei et al., “Supramolecular prodrug micelles based on the complementary multiple hydrogen bonds as drug delivery platform for thrombosis therapy,” RSC Advances, vol. 6, no. 67, pp. 62478–62484, 2016. View at Publisher · View at Google Scholar
  74. R. Badalzadeh, B. Yousefi, M. Majidinia, and H. Ebrahimi, “Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel,” Journal of Physiological Sciences, vol. 64, no. 6, pp. 393–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. K. S. Jayachandran, A. H. R. Vasanthi, and N. Gurusamy, “Steroidal saponin diosgenin from Dioscorea bulbifera protects cardiac cells from hypoxia-reoxygenation injury through modulation of pro-survival and pro-death molecules,” Pharmacognosy Magazine, vol. 12, supplement 1, pp. S14–S20, 2016. View at Google Scholar
  76. R. Badalzadeh, B. Yousefi, A. Tajaddini, and N. Ahmadian, “Diosgenin-induced protection against myocardial ischaemia-reperfusion injury is mediated by mitochondrial KATP channels in a rat model,” Perfusion, vol. 30, no. 7, pp. 565–571, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Ebrahimi, R. Badalzadeh, M. Mohammadi, and B. Yousefi, “Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels,” Journal of Physiology and Biochemistry, vol. 70, no. 2, pp. 425–432, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Badalzadeh, R. Yavari, and D. Chalabiani, “Mitochondrial ATP-sensitive K+ channels mediate the antioxidative influence of diosgenin on myocardial reperfusion injury in rat hearts,” General physiology and biophysics, vol. 34, no. 3, pp. 323–329, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Zhao, F. Niu, C.-Y. Xu et al., “Diosgenin prevents bone loss on retinoic acid-induced osteoporosis in rats,” Irish Journal of Medical Science, vol. 185, no. 3, pp. 581–587, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. Z. Zhang, C. Song, X. Fu et al., “High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio,” International Journal of Molecular Sciences, vol. 15, no. 9, pp. 17130–17147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. M. A. Tikhonova, C.-H. Ting, N. G. Kolosova et al., “Improving bone microarchitecture in aging with diosgenin treatment: a study in senescence-accelerated OXYS rats,” Chinese Journal of Physiology, vol. 58, no. 5, pp. 322–331, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. H. Cai, Z. Wang, H.-Q. Zhang et al., “Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease,” Acta Pharmacologica Sinica, vol. 35, no. 1, pp. 65–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Tohda, Y.-A. Lee, Y. Goto, and I. Nemere, “Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS,” Scientific Reports, vol. 3, article no. 3395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Tambe, P. Jain, S. Patil, P. Ghumatkar, and S. Sathaye, “Protective effects of diosgenin in pentylenetetrazole induced kindling model of epilepsy in mice,” Neurochemistry Neuropharmacology Journals. Open Access, vol. 1, article 106, 2015. View at Google Scholar
  85. C. Y. Cheok, H. A. K. Salman, and R. Sulaiman, “Extraction and quantification of saponins: a review,” Food Research International, vol. 59, pp. 16–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. B. Yang, Z. Liu, J. Hu, X. Lai, and P. Xia, “Quantitative determination of sarsasapogenin in rat plasma using liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B, vol. 1022, pp. 213–219, 2016. View at Publisher · View at Google Scholar
  87. K. Taketani, S. Hoshino, T. Uemura et al., “An efficient purification method for quantitative determinations of protodioscin, Dioscin and Diosgenin in plasma of fenugreek-fed mice,” Journal of Nutritional Science and Vitaminology, vol. 61, no. 6, pp. 465–470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Wang, J.-H. Liu, X. Guo, J. Zhang, and B.-Y. Yu, “A sensitive indirect competitive enzyme-linked immunosorbent assay for the detection of sarsasapogenin in rat plasma,” Acta Pharmacologica Sinica, vol. 31, no. 8, pp. 984–989, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. X. Cao, Z. Yao, H. Chen et al., “Development and validation of a liquid chromatography/tandem mass spectrometry assay for the quantification of methyl protodioscin in rat plasma: application to a pharmacokinetic study,” Biomedical Chromatography, vol. 22, no. 4, pp. 408–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Q. Zhang, J. H. Liang, E. H. Fu, and B. X. Li, “Effect of modified enzymatic catalysis on the extraction of diosgenin from Dioscorea zingiberensis C. H. Wright,” Chemical Engineering and Technology, vol. 30, no. 11, pp. 1488–1494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Xu, X. Han, D. Dong et al., “Efficient protocol for purification of diosgenin and two fatty acids from Rhizoma dioscoreae by SFE coupled with high-speed counter-current chromatography and evaporative light scattering detection,” Journal of Separation Science, vol. 31, no. 20, pp. 3638–3646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Kaufmann, S. Rudaz, S. Cherkaoui, J.-L. Veuthey, and P. Christen, “Influence of plant matrix on microwave-assisted extraction process. The case of diosgenin extracted from fenugreek (Trigonella foenum-graecum L.),” Phytochemical Analysis, vol. 18, no. 1, pp. 70–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Li, Y. Mou, S. Lu et al., “Quantitative determination of diosgenin in Dioscorea zingiberensis cell cultures by microplate-spectrophotometry and high-performance liquid chromatography,” African Journal of Pharmacy and Pharmacology, vol. 6, pp. 1186–1193, 2012. View at Google Scholar
  94. H. A. Deshpande and S. R. Bhalsing, “Isolation and characterization of diosgenin from in vitro cultured tissues of Helicteres isora L,” Physiology and Molecular Biology of Plants, vol. 20, no. 1, pp. 89–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Puri, T. C. Wong, and R. K. Puri, “Solasodine and diosgenin: 1H and 13C assignments by two-dimensional NMR spectroscopy,” Magnetic Resonance in Chemistry, vol. 31, no. 3, pp. 278–282, 1993. View at Google Scholar
  96. P. K. Agrawal, D. C. Jain, and A. K. Pathak, “NMR spectroscopy of steroidal sapogenins and steroidal saponins: an update,” Magnetic Resonance in Chemistry, vol. 33, pp. 923–953, 1993. View at Google Scholar
  97. P. D. Trivedi, K. Pundarikakshudu, S. Rathnam, and K. S. Shah, “A validated quantitative thin-layer chromatographic method for estimation of diosgenin in various plant samples, extract, and market formulation,” Journal of AOAC International, vol. 90, pp. 358–363, 2007. View at Google Scholar
  98. L. Wang, X. Wang, X. Yuan, and B. Zhao, “Simultaneous analysis of diosgenin and sarsasapogenin in Asparagus officinalis byproduct by thin-layer chromatography,” Phytochemical Analysis, vol. 22, no. 1, pp. 14–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Attimarad, K. K. M. Ahmed, B. E. Aldhubaib, and S. Harsha, “High-performance thin layer chromatography: a powerful analytical technique in pharmaceutical drug discovery,” Pharmaceutical Methods, vol. 2, no. 2, pp. 71–75, 2011. View at Publisher · View at Google Scholar
  100. D. Nagore, P. Patil, and V. Kuber, “Comparison between high performance liquid chromatography and high performance thin layer chromatography determination of Diosgenin from fenugreek seeds,” International Journal of Green Pharmacy, vol. 6, no. 4, pp. 315–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Ghodasara, R. Gaudani, B. Nayak, and D. Shingala, “HPTLC method development and validation for the simultaneous estimation of diosgenin and gallic acid in marketed formulation,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, pp. 2664–2672, 2012. View at Google Scholar
  102. O. Laila, I. Murtaza, M. Z. Abdin, S. Ahmad, N. A. Ganai, and M. Jehangir, “Development and validation of HPTLC method for simultaneous estimation of diosgenin and quercetin in fenugreek seeds (Trigonella foenum-graceum),” ISRN Chromatography, vol. 2014, Article ID 583047, 8 pages, 2014. View at Publisher · View at Google Scholar
  103. R. Dangi, A. Misar, S. Tamhankar, and S. Rao, “Diosgenin content in some Trigonella species,” Indian Journal of Advances in plant Research, vol. 1, pp. 47–51, 2014. View at Google Scholar
  104. U. Keshwar, S. Pimplapure, S. Dhurde, and B. Shrikhande, “Development and validation of HPTLC method for determination of diosgenin in polyherbal tablet,” International Journal of Ayurvedic And Herbal Medicine, vol. 5, pp. 1701–1706, 2015. View at Google Scholar
  105. S. Parameswaran and S. Koshti, “Quantitative estimation of piperine and diosgenin in ayurvedic formulation,” British Journal of Pharmaceutical Research, vol. 4, no. 8, pp. 910–919, 2014. View at Publisher · View at Google Scholar
  106. W. G. Taylor, M. S. Zaman, Z. Mir et al., “Analysis of steroidal sapogenins from amber fenugreek (Trigonella foenum-graecum) by capillary gas chromatography and combined gas chromatography/mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 45, no. 3, pp. 753–759, 1997. View at Publisher · View at Google Scholar · View at Scopus
  107. W. G. Taylor, J. L. Elder, P. R. Chang, and K. W. Richards, “Microdetermination of diosgenin from fenugreek (Trigonella foenum-graecum) seeds,” Journal of Agricultural and Food Chemistry, vol. 48, no. 11, pp. 5206–5210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. W. G. Taylor, H. J. Zulyniak, K. W. Richards, S. N. Acharya, S. Bittman, and J. L. Elder, “Variation in diosgenin levels among 10 accessions of fenugreek seeds produced in western Canada,” Journal of Agricultural and Food Chemistry, vol. 50, no. 21, pp. 5994–5997, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. M. de Lourdes Contreras-Pacheco, F. Santacruz-Ruvalcaba, J. A. García-Fajardo et al., “Diosgenin quantification, characterisation and chemical composition in a tuber collection of Dioscorea spp. in the state of Jalisco, Mexico,” International Journal of Food Science and Technology, vol. 48, no. 10, pp. 2111–2118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. K. Patel, M. Gadewar, V. Tahilyani, and D. K. Patel, “A review on pharmacological and analytical aspects of diosgenin: a concise report,” Natural Products and Bioprospecting, vol. 2, no. 2, pp. 46–52, 2012. View at Publisher · View at Google Scholar
  111. D. Guillarme and M. W. Dong, “Newer developments in HPLC impacting pharmaceutical analysis: a brief review,” American Pharmaceutical Review, vol. 16, no. 4, pp. 36–43, 2013. View at Google Scholar
  112. B. P. Chapagain and Z. Wiesman, “Determination of saponins in the kernel cake of Balanites aegyptiaca by HPLC-ESI/MS,” Phytochemical Analysis, vol. 18, no. 4, pp. 354–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. D.-J. Yang, T.-J. Lu, and L. S. Hwang, “Simultaneous determination of furostanol and spirostanol glycosides in Taiwanese yam (Dioscorea spp.) cultivars by high performance liquid chromatography,” Journal of Food and Drug Analysis, vol. 11, no. 4, pp. 271–276, 2003. View at Google Scholar · View at Scopus
  114. J. Niño, D. A. Jiménez, O. M. Mosquera, and Y. M. Correa, “Diosgenin quantification by HPLC in a Dioscorea polygonoides tuber collection from Colombian flora,” Journal of the Brazilian Chemical Society, vol. 18, no. 5, pp. 1073–1076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. N. A. Ahmed Kaid, M. B. Norbaiyah, M. A. Imad, and M. H. Norazian, “Quantification of anti-fertility compound-Diosgenin concentration in the fenugreek seeds aqueous extract (FSA),” The International Medical Journal of Malaysia, vol. 15, pp. 75–80, 2016. View at Google Scholar
  116. H. Yang, B. Chen, X.-B. Wang et al., “Rapid quantitative analysis of diosgenin in the tubers of Dioscorea zingiberensis C.H. Wright by coupling cellulose enzymolysis and two-phase acid hydrolysis in tandem with HPLC-UV,” Natural Product Research, vol. 27, no. 20, pp. 1933–1935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Yi, L.-L. Fan, H.-L. Chen et al., “Comparative analysis of diosgenin in Dioscorea species and related medicinal plants by UPLC-DAD-MS,” BMC Biochemistry, vol. 15, no. 1, article no. 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Jayaprakasam, K. Ravit, A. Kuriakose, and B. Asha Jyothi, “Quantitative determination of diosgenin in polyherbal formulation and various extracts of Smilax China Linn using utandard marker by validated analytical techniques,” Universal Journal of Pharmacy, vol. 2, no. 4, pp. 83–90, 2013. View at Google Scholar
  119. S. Desai, P. Tatke, and S. Y. Gabhe, “Quantification of diosgenin in extracts and formulations containing Solanum nigrum,” International Journal of Pharmaceutical Sciences and Research, vol. 6, pp. 676–681, 2015. View at Google Scholar
  120. W.-T. Hwang, Y.-S. Kim, C.-K. Hong, J. Lee, and D. Park, “Simple stability-indicating validated HPLC method for diosgenin in cosmeceutical formulations with long term stability application for light and heat,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 5, pp. 466–471, 2011. View at Google Scholar · View at Scopus
  121. V. B. Warke, T. A. Deshmukh, and V. R. Patil, “Development and validation of RP-HPLC method for estimation of diosgenin in pharmaceutical dosage form,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, no. 1, pp. 126–128, 2011. View at Google Scholar · View at Scopus
  122. P. K. Gupta, D. H. Nagore, V. V. Kuber, and S. Purohit, “A validated RP-HPLC method for the estimation of diosgenin from polyherbal formulation containing Tribulus terrestris Linn,” Asian Journal of Pharmaceutical and Clinical Research, vol. 5, no. 4, pp. 91–94, 2012. View at Google Scholar · View at Scopus
  123. B. Avula, Y.-H. Wang, Z. Ali, T. J. Smillie, and I. A. Khan, “Chemical fingerprint analysis and quantitative determination of steroidal compounds from Dioscorea villosa, Dioscorea species and dietary supplements using UHPLC-ELSD,” Biomedical Chromatography, vol. 28, no. 2, pp. 281–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. H. Li, X. Wang, Y. Ma et al., “Purification and characterization of a glycosidase with hydrolyzing multi-3-O-glycosides of spirostanol saponin activity from Gibberella intermedia,” Journal of Molecular Catalysis B: Enzymatic, vol. 128, pp. 46–51, 2016. View at Google Scholar
  125. S. M. Duckstein and F. C. Stintzing, “LC-MSn characterization of steroidal saponins in Helleborus niger L. roots and their conversion products during fermentation,” Steroids, vol. 93, pp. 47–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. B. P. Chapagain and Z. Wiesman, “Metabolite profiling of saponins in Balanites aegyptiaca plant tissues using LC (RI)-ESI/MS and MALDI-TOF/MS,” Metabolomics, vol. 4, no. 4, pp. 357–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. S.-S. Qi, Y.-S. Dong, Y.-K. Zhao, and Z.-L. Xiu, “Qualitative and quantitative analysis of microbial transformation of steroidal saponins in dioscorea zingiberensis,” Chromatographia, vol. 69, no. 9-10, pp. 865–870, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. Y. Ren, Y. Chen, B. Hu, H. Wu, F. Lai, and X. Li, “Microwave-assisted extraction and a new determination method for total steroid saponins from Dioscorea zingiberensis C.H. Wright,” Steroids, vol. 104, pp. 145–152, 2015. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Li, D. Yang, K. Yu, J. He, and Y. Zhang, “Determination of diosgenin content in medicinal plants with enzyme-linked immunosorbent assay,” Planta Medica, vol. 76, no. 16, pp. 1915–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. N. Gong, B. Zhang, F. Hu et al., “Development of a new certified reference material of diosgenin using mass balance approach and Coulometric titration method,” Steroids, vol. 92, pp. 25–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. L. P. Meagher, B. L. Smith, and A. L. Wilkins, “Metabolism of diosgenin-derived saponins: implications for hepatogenous photosensitization diseases in ruminants,” Animal Feed Science and Technology, vol. 91, no. 3-4, pp. 157–170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  132. L. J. Liu, Y. Q. Liu, Y. R. Chang, Q. J. Li, and B. X. Wang, “GC-MS determination of diosgenin in rats plasma,” Chinese Journal of Pharmaceutical Analysis, vol. 26, pp. 177–180, 2006. View at Google Scholar
  133. Y.-N. Tang, Y.-X. Pang, X.-C. He et al., “UPLC-QTOF-MS identification of metabolites in rat biosamples after oral administration of Dioscorea saponins: a comparative study,” Journal of Ethnopharmacology, vol. 165, pp. 127–140, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. L. Xu, Y. Liu, T. Wang et al., “Development and validation of a sensitive and rapid non-aqueous LC-ESI-MS/MS method for measurement of diosgenin in the plasma of normal and hyperlipidemic rats: a comparative study,” Journal of Chromatography B, vol. 877, no. 14-15, pp. 1530–1536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Okawara, Y. Tokudome, H. Todo, K. Sugibayashi, and F. Hashimoto, “Effect of ß-cyclodextrin derivatives on the diosgenin absorption in caco-2 cell monolayer and rats,” Biological and Pharmaceutical Bulletin, vol. 37, no. 1, pp. 54–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Okawara, F. Hashimoto, H. Todo, K. Sugibayashi, and Y. Tokudome, “Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats,” International Journal of Pharmaceutics, vol. 472, no. 1-2, pp. 257–261, 2014. View at Publisher · View at Google Scholar · View at Scopus